Reuters: CIO Bill Smead discusses potential Pfizer and AstraZeneca deal
Pfizer expected to be patient in face of AstraZeneca rejection By Bill Berkrot For more information go to www.reuters.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of